InvestorsHub Logo

Photog

07/18/17 10:50 AM

#16608 RE: SAMNOTSAMUEL #16607

Thx Sam! Guess I've got a lot to learn in this game.

ice1234

07/18/17 11:21 AM

#16612 RE: SAMNOTSAMUEL #16607

Strong Buy ~(DCTH)' Selling it medication in Europe -expending -in US =FDA push on fast track 'Delcath Systems, Inc. (DCTH)' chemosaturation system. Its clinical trial include a Phase III multi-center study for patients with unresectable metastatic ocular or cutaneous melanoma exclusively or predominantly in the liver; and a multi-arm Phase II clinical trial of the Delcath chemosaturation system with melphalan in patients with primary and metastatic liver cancer, which comprise neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma. Delcath Systems, Inc. was founded in 1988-Management getting reach salaries depreciating (DCTH shares in order get control of the beard - They Know (DCTH) worth more then $16 dollars a share/